Mauna Kea Technologies

OverviewSuggest Edit

Mauna Kea Technologies is a global medical device company dedicated to the advent of optical biopsy. The company researches, develops and markets innovative tools to visualize and detect cellular abnormalities during endoscopic procedures. Its flagship product, Cellvizio®, a probe-­based Confocal Laser Endomicroscopy (pCLE) system, provides physicians and researchers high-­resolution cellular views of tissue inside the body. Large, international, multi-center clinical trials have demonstrated Cellvizio's ability to help physicians more accurately detect early forms of disease and make treatment decisions immediately. Designed to improve patient outcomes and reduce costs within a hospital, Cellvizio can be used with almost any endoscope. Cellvizio has 510(k) clearance from the U.S. Food and Drug Administration and the European CE-­‐Mark for use in the GI tract, biliary and pancreatic ducts and lungs.
TypePublic
Founded2000
HQParis, FR
Websitemaunakeatech.com
Employee Ratings4

Latest Updates

Employees (est.) (Jun 2022)87(-12%)
Revenue (FY, 2021)€7.7 M(+18%)
Share Price (Jun 2022)€0.5(-4%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Mauna Kea Technologies

François Lacombe

François Lacombe

Chief Scientific Officer
Christopher D. McFadden

Christopher D. McFadden

Director
Aline Criton

Aline Criton

Chief Clinical and Regulatory Affairs Officer
Joseph Devivo

Joseph Devivo

Director
Nicolas Bouvier

Nicolas Bouvier

Interim Chief Executive Officer
Claire Biot

Claire Biot

Director
Show more

Mauna Kea Technologies Office Locations

Mauna Kea Technologies has an office in Paris
Paris, FR (HQ)
9 Rue d'Enghien
Show all (1)

Mauna Kea Technologies Financials and Metrics

Mauna Kea Technologies Revenue

Mauna Kea Technologies's revenue was reported to be €7.7 m in FY, 2021
EUR

Revenue (FY, 2021)

7.7m

Gross profit (FY, 2021)

7.7m

Net income (FY, 2021)

(13.4m)

EBITDA (FY, 2021)

(10.7m)

EBIT (FY, 2021)

(12.2m)

Market capitalization (29-Jun-2022)

22.8m

Closing stock price (29-Jun-2022)

0.5

Cash (31-Dec-2021)

11.9m

EV

39.6m
Mauna Kea Technologies's current market capitalization is €22.8 m.
Annual
EURFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

6.8m7.4m6.5m7.7m

Cost of goods sold

(2.1m)(2.3m)(1.3m)(1.2m)

Gross profit

5.8m6.2m6.7m7.7m

R&D expense

(1.5m)(614.0k)(877.0k)(581.0k)
Half Year
EURH1, 2019H1, 2020H1, 2021

Revenue

3.9m2.1m3.3m

Cost of goods sold

(1.5m)(848.0k)(580.0k)

Gross profit

3.0m2.3m3.3m

R&D expense

(583.0k)(377.0k)(315.0k)
Annual
EURFY, 2018FY, 2019FY, 2020FY, 2021

Cash

8.6m10.0m8.6m11.9m

Accounts Receivable

1.6m2.4m1.9m1.5m

Prepaid Expenses

2.8m2.3m405.0k2.1m

Inventories

2.5m2.6m2.7m3.0m
Half Year
EURH1, 2019H1, 2020H1, 2021

Cash

4.2m3.4m

Accounts Receivable

2.0m1.7m1.2m

Prepaid Expenses

1.3m2.0m1.8m

Inventories

2.4m2.8m2.7m
Annual
EURFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

(12.8m)(15.3m)(12.8m)(13.4m)

Depreciation and Amortization

1.1m1.2m1.3m2.2m

Inventories

(313.0k)(238.0k)(344.0k)180.0k

Accounts Payable

419.0k155.0k(794.0k)186.0k
Half Year
EURH1, 2019H1, 2020H1, 2021

Net Income

(8.1m)(6.7m)(6.7m)

Depreciation and Amortization

692.0k700.0k672.0k

Inventories

92.0k(26.0k)285.0k

Accounts Payable

(366.0k)(335.0k)699.0k
EURFY, 2018

Revenue/Employee

68.3k
Show all financial metrics

Mauna Kea Technologies Revenue Breakdown

Embed Graph

Mauna Kea Technologies revenue breakdown by business segment: 41.5% from SALES OF EQUIPMENT, 41.6% from SALES OF ACCESSORIES:MINI-PROBES, SOFTWARE and 16.9% from SERVICES

Mauna Kea Technologies revenue breakdown by geographic segment: 54.3% from ETATS-UNIS D'AMÉRIQUE, 21.8% from EMEA (EUROPE, MOYEN ORIENT, AFRIQUE), 17.9% from CHINA and 5.9% from Other

Mauna Kea Technologies Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Mauna Kea Technologies Online and Social Media Presence

Embed Graph

Mauna Kea Technologies News and Updates

Juncker Plan: 22.5 million for Mauna Kea Technologies

Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy platform, and the European Investment Bank (EIB), which is the Bank of the European Union (EU), announce the signing of a €22.5 million loan agreement, supported by the Eur…

Mauna Kea Technologies Frequently Asked Questions

  • When was Mauna Kea Technologies founded?

    Mauna Kea Technologies was founded in 2000.

  • Who are Mauna Kea Technologies key executives?

    Mauna Kea Technologies's key executives are François Lacombe, Christopher D. McFadden and Aline Criton.

  • How many employees does Mauna Kea Technologies have?

    Mauna Kea Technologies has 87 employees.

  • What is Mauna Kea Technologies revenue?

    Latest Mauna Kea Technologies annual revenue is €7.7 m.

  • What is Mauna Kea Technologies revenue per employee?

    Latest Mauna Kea Technologies revenue per employee is €88.5 k.

  • Who are Mauna Kea Technologies competitors?

    Competitors of Mauna Kea Technologies include Koh Young Technology, Becton Dickinson and Biovotion.

  • Where is Mauna Kea Technologies headquarters?

    Mauna Kea Technologies headquarters is located at 9 Rue d'Enghien, Paris.

  • Where are Mauna Kea Technologies offices?

    Mauna Kea Technologies has an office in Paris.

  • How many offices does Mauna Kea Technologies have?

    Mauna Kea Technologies has 1 office.